Previous product
Back to products
Fotivda (tivozanib)
CHF4,511.72
Next product
Reblozyl (luspatercept)
CHF2,168.60
Cosela (trilaciclib)
CHF2,581.69
Cosela (trilaciclib) is a medication to reduce the damage done on the bone marrow by chemotherapy (myelosuppression) in adult patients with extensive-stage small cell lung cancer (ES-SCLC) prior to receiving chemotherapy.
Reviews
There are no reviews yet.